BAL1 and Its Partner E3 Ligase, BBAP, link poly(ADP-Ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8

Molecular and Cellular Biology

Volumn 33, Issue 4, 2013, Pages 845-857

  Yan, Qingsheng ^a   Xu, Rong ^a   Zhu, Liya ^a   Cheng, Xin ^a   Wang, Zhe ^a   Manis, John ^b   Shipp, Margaret A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; B LYMPHOMA AND BAL ASSOCIATED PROTEIN; BINDING PROTEIN; BRCA1 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; P53 BINDING PROTEIN 1; PROTEIN; PROTEIN BAL1; PROTEIN MDC1; PROTEIN RNF8; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LASER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84873855937     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00990-12     Document Type: Article

References (32)

1. Polo SE, Jackson SP. 2011. Dynamics of DNA damage response proteins atDNAbreaks: a focus on protein modifications. Genes Dev. 25:409-433.
2. Ciccia A, Elledge SJ. 2010. The DNA damage response: making it safe to play with knives. Mol. Cell 40:179-204.
3. Ahel D, Horejsi Z, Wieckens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP, Owen-Hughes T, Boulton SJ. 2009. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325:1240-1243.
4. Krishnakumar R, Kraus WL. 2010. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 39: 8-24.
5. Aguiar R, Yakushijin Y, Kharbanda S, Salgia R, Fletcher J, Shipp M. 2000. BAL is a novel risk-related gene in diffuse large B-cell lymphomas which enhances cellular migration. Blood 96:4328-4334.
6. Aguiar RCT, Takeyama K, He C, Kreinbrink K, Shipp M. 2005. B-aggressive lymphoma (BAL) family proteins have unique domains which modulate transcription and exhibit PARP activity. J. Biol. Chem. 280: 33756-33765.
7. Han W, Li X, Fu X. 2011. The macro domain protein family: structure, functions, and their potential therapeutic implications. Mutat. Res. 727: 86-103.
8. Hottiger MO, Hassa PO, Luscher B, Schuler H, Koch-Nolte F. 2010. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 35:208-219.
9. Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, Nijmeijer B, Colombelli J, Altmeyer M, Stelzer EH, Scheffzek K, Hottiger MO, Ladurner AG. 2009. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat. Struct. Mol. Biol. 16:923-929.
10. Gottschalk AJ, Timinszky G, Kong SE, Jin J, Cai YSSK, Washburn MP, Florens L, Ladumer AG, Conaway RC. 2009. Poly(ADP-ribosyl)ation directs recruitment and activation to an ATP-dependent chromatin remodeler. Proc. Natl. Acad. Sci. U. S. A. 106:13770-13774.
11. Takeyama K, Aguiar RCT, Gu L, He C, Freeman GJ, Kutok JL, Aster JC, Shipp MA. 2003. The BAL-binding protein, BBAP, and related Deltex family members exhibit E3 ubiquitin ligase activity. J. Biol. Chem. 278: 21930-21937.
12. Juszczynski P, Kutok JL, Li C, Mitra J, Aguiar RC, Shipp MA. 2006. BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate. Mol. Cell. Biol. 26:5348-5359.
13. Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC, Dal Cin P, Ladd C, Pinkus GS, Salles G, Harris NL, Dalla-Favera R, Habermann TM, Aster JC, Golub TR, Shipp MA. 2005. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105:1851-1861.
14. Yan Q, Dutt S, Xu R, Graves K, Juszczynski P, Manis JP, Shipp MA. 2009. BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response. Mol. Cell 36:110-120.
15. Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, Chen J. 2007. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131:901-914.
16. Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, Lukas J. 2007. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131:887-900.
17. Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R, Ellenberg J, Panier S, Durocher D, Bartek J, Lukas J, Lukas C. 2009. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 136:435-446.
18. Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD, Panier S, Mendez M, Wildenhain J, Thomson TM, Pelletier L, Jackson SP, Durocher D. 2007. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318:1637-1640.
19. Sobhian B, Shao G, Lilli DR, Culhane AC, Moreau LA, Xia B, Livingston DM, Greenberg RA. 2007. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316:1198-1202.
20. Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, Nakada S, Ylanko J, Olivarius S, Mendez M, Oldreive C, Wildenhain J, Tagliaferro A, Pelletier L, Taubenheim N, Durandy A, Byrd PJ, Stankovic T, Taylor AM, Durocher D. 2009. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites ofDNAdamage. Cell 136:420-434.
21. Wang B, Elledge SJ. 2007. Ubc13/Rnf8 ubiqutin ligases control foci formation of the Rap80/Abraxas/Brcc36 complex in response to DNA damage. Proc. Natl. Acad. Sci. U. S. A. 104:20759-20763.
22. Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi SP, Elledge SJ. 2007. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316:1194-1198.
23. Hu Y, Scully R, Sobhian B, Xie A, Shestakova E, Livingston DM. 2011. RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci. Genes Dev. 25:685-700.
24. Kim H, Chen J, Yu X. 2007. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316:1202-1205.
25. Yelamos J, Monreal Y, Saenz L, Aguado E, Schreiber V, Mota R, Fuente T, Minguela A, Parrilla P, de Murcia G, Almarza E, Aparicio P, Menissier-de Murcia J. 2006. PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes. EMBO J. 25:4350-4360.
26. Olive PI, Banath JP. 2006. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1:23-29.
27. Lok GT, Sy SM, Dong SS, Ching YP, Tsao SW, Thomson TM, Huen MS. 2012. Differential regulation of RNF8-mediated Lys48- and Lys63-based poly-ubiquitylation. Nucleic Acids Res. 40:196-205.
28. Hassa PO. 2009. The molecular "Jekyll and Hyde" duality of PARP1 in cell death and cell survival. Front. Biosci. 14:72-111.
29. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A. 2003. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5:675-679.
30. Balmana J, Domchek SM, Tutt A, Garber JE. 2011. Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers. Cancer Discov. 1:29-34.
31. Ellisen LW. 2011. PARP inhibitors in cancer therapy: promise, progress, and puzzles. Cancer Cell 19:165-167.
32. O'Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C. 2011. Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N. Engl. J. Med. 364:205-214.